Clinical diagnostics is undergoing a transformative shift, driven by rapid innovation and a growing emphasis on holistic, patient-centered care. William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, shared in Modern Healthcare how platform business models support this shift toward solutions that provide more comprehensive, meaningful answers to clinical questions.

“Clinical diagnostics are at the threshold of a whole new era,” says Dr. Morice. “Innovators are creating technologies and tools at an unprecedented pace, and the diagnostics industry is improving how clinicians can leverage them to get answers.”

For Mayo Clinic Laboratories, embracing a platform approach meant incorporating diagnostic innovations from external collaborators in addition to offering Mayo Clinic-developed tests. This model enables clinicians to access a broad range of tests in one place, improving care coordination and decision-making.

The success of such platforms depends on collaborations built on shared values, a clear value proposition, mutual benefit, and ongoing transparency. By fostering collaboration through these principles, platforms not only centralize diagnostic tools to streamline access but also accelerate innovation. They help identify unmet clinical needs, repurpose existing tools for new applications, and close diagnostic gaps more efficiently.

Dr. Morice shares that ultimately, this integrated approach is revolutionizing diagnostics as platforms enable more personalized care, better patient outcomes, and advances in laboratory medicine. Read the full article.